OpenSAFELY
Reports

Vaccine Coverage - Second Doses

Description
Weekly* report on COVID-19 vaccination coverage in England focussing on second doses which are due (i.e. where first dose was recorded at least 14 weeks ago). * please note, updates will occur most weeks but not all.
Contact
Get in touch and tell us how you use this report or new features you'd like to see: [email protected]
First published
02 Jul 2021
Last updated
30 Nov 2021

http://doi.org/10.53764/rpt.cd7cf36769

Links

OpenSAFELY COVID Vaccine coverage report: Second doses

OpenSAFELY is a new secure analytics platform for electronic patient records built on behalf of NHS England to deliver urgent academic and operational research during the pandemic.

This is an extension of our regular weekly report on COVID-19 vaccination coverage in England using data from 40% of general practices that use TPP electronic health record software. The data requires careful interpretation and there are a number of caveats. Please read the full detail about our methods and discussion of our earlier results (as of January 13th) in our preprint paper available here.

The full analytical methods behind the latest results in this report are available here.

Second doses

Please note This report is intended to highlight any differences between subgroups of priority cohorts in receiving second doses, only including those which are due (i.e. where at least 14 weeks has passed since the first dose). It is therefore NOT a comprehensive view of all second doses given to date - to see these figures please refer to the main report.

New: now includes everyone over 18 and a breakdown by brand of first dose

Report last updated 30 Nov 2021

Second dose vaccinations included up to 24 Nov 2021 inclusive

Only persons who had their first dose between the start of the campaign (7 Dec 2020) and 14 weeks ago (18 Aug 2021) are included in the 'due' group.

Contents

Cumulative second dose vaccination figures among:

SUMMARY

Group definitions

  • As of 29 Nov 2021, patient age is calculated at 31 Aug 2021 (previously 31 March 2021), in line with national reporting.
  • The care home group is defined based on patients (aged 65+) having one of these codes.
  • The shielding group is defined based on patients (aged 16-69) having one of these codes provided it was not superceded by one of these codes.
  • The LD (learning disability) group is defined based on patients (aged 16-64) having one of these codes and excludes people who are shielding.
  • Patients are counted in their highest risk category only; e.g. a 65-year-old who is shielding is only counted in the shielding group, not in the 65-69 group.
  • The housebound group is defined based on this codelist and excludes people who were later recorded as not housebound or in a care home.

Back to top

Cumulative second dose vaccination figures among 80+ population

Please refer to footnotes below table for information.

Second Doses due at 24 Nov (n) Second doses overdue (n) Second doses given (n) Second doses given (% of due) Total population
Category Group
overall overall 1,061,683 5,761 1,055,922 99.5 1,102,570
Sex F 612,514 3,738 608,776 99.4 636,706
M 449,162 2,023 447,139 99.5 465,864
Age band 80-84 562,471 2,625 559,846 99.5 582,652
85-89 334,033 1,897 332,136 99.4 346,535
90+ 165,172 1,232 163,940 99.3 173,376
Ethnicity (broad categories) Black 8,561 210 8,351 97.5 11,004
Mixed 2,786 42 2,744 98.5 3,304
Other 5,691 84 5,607 98.5 6,776
South Asian 25,186 434 24,752 98.3 28,420
Unknown 44,065 322 43,743 99.3 51,541
White 975,394 4,676 970,718 99.5 1,001,518
ethnicity 16 groups African 1,463 49 1,414 96.7 2,086
Bangladeshi or British Bangladeshi 1,106 28 1,078 97.5 1,302
Caribbean 6,027 126 5,901 97.9 7,511
Chinese 1,407 21 1,386 98.5 1,722
Other 4,277 63 4,214 98.5 5,047
Other Asian 3,808 49 3,759 98.7 4,466
British or Mixed British 926,604 4,291 922,313 99.5 949,046
Indian or British Indian 13,853 119 13,734 99.1 15,064
Irish 9,121 70 9,051 99.2 9,569
Other Black 1,071 28 1,043 97.4 1,407
Other White 39,662 322 39,340 99.2 42,896
Other mixed 1,036 7 1,029 99.3 1,176
Pakistani or British Pakistani 6,419 238 6,181 96.3 7,588
Unknown 44,086 322 43,764 99.3 51,562
White + Asian 490 7 483 98.6 546
White + Black African 280 0 280 100.0 385
White + Black Caribbean 966 14 952 98.6 1,197
Index of Multiple Deprivation (quintiles) 1 Most deprived 131,516 1,267 130,249 99.0 140,224
2 174,797 1,211 173,586 99.3 183,225
3 238,686 1,225 237,461 99.5 247,310
4 248,157 1,071 247,086 99.6 255,892
5 Least deprived 249,060 847 248,213 99.7 255,388
Unknown 19,467 140 19,327 99.3 20,531
BMI 30+ 188,657 910 187,747 99.5 193,319
under 30 873,019 4,844 868,175 99.4 909,244
Housebound no 953,022 4,340 948,682 99.5 989,765
yes 108,661 1,428 107,233 98.7 112,798
Chronic cardiac disease no 738,409 4,032 734,377 99.5 770,938
yes 323,274 1,736 321,538 99.5 331,625
Current COPD no 949,067 5,096 943,971 99.5 987,133
yes 112,609 665 111,944 99.4 115,430
Dialysis no 1,059,667 5,747 1,053,920 99.5 1,100,498
yes 2,009 14 1,995 99.3 2,065
DMARDs no 1,027,824 5,600 1,022,224 99.5 1,068,074
yes 33,859 168 33,691 99.5 34,489
Dementia no 978,726 4,914 973,812 99.5 1,016,449
yes 82,957 854 82,103 99.0 86,114
Psychosis, schizophrenia, or bipolar no 1,054,025 5,649 1,048,376 99.5 1,094,380
yes 7,651 112 7,539 98.5 8,183
Learning disability no 1,061,193 5,754 1,055,439 99.5 1,102,059
yes 483 7 476 98.6 511
SSRI (last 12 months) no 1,018,913 5,488 1,013,425 99.5 1,058,953
yes 42,763 266 42,497 99.4 43,610
Chemo or radiotherapy no 1,024,513 5,600 1,018,913 99.5 1,064,595
yes 37,170 168 37,002 99.5 37,968
Cancer (lung) no 1,054,249 5,719 1,048,530 99.5 1,094,961
yes 7,427 35 7,392 99.5 7,602
Cancer (excluding lung/haem) no 865,256 4,928 860,328 99.4 901,761
yes 196,427 840 195,587 99.6 200,802
Cancer (haematological) no 1,041,502 5,670 1,035,832 99.5 1,081,955
yes 20,174 91 20,083 99.5 20,608
brand of first dose Moderna 105 14 91 86.7 238
Oxford-AZ 289,478 3,738 285,740 98.7 289,597
Pfizer 771,407 1,995 769,412 99.7 776,356
Unknown 686 14 672 98.0 693

Footnotes:

  • Patient counts rounded to the nearest 7
  • Only persons who are currently registered and had their fist dose at least 14 weeks ago are included in the 'due' group.
  • Population excludes those known to live in an elderly care home, based upon clinical coding.
  • SSRIs group excludes individuals with Psychosis/ schizophrenia/bipolar, LD, or Dementia.

Second Doses Overdue Among 80+ Population

Second doses which have not been given at least 14 weeks since the first dose

Error bars indicate possible error caused by rounding

Back to top

Cumulative second dose vaccination figures among 70-79 population

Please refer to footnotes below table for information.

Second Doses due at 24 Nov (n) Second doses overdue (n) Second doses given (n) Second doses given (% of due) Total population
Category Group
overall overall 2,008,797 10,283 1,998,514 99.5 2,097,998
Sex F 1,054,991 5,726 1,049,265 99.5 1,100,582
M 953,799 4,557 949,242 99.5 997,402
Age band 70-74 1,142,596 6,216 1,136,380 99.5 1,198,687
75-79 866,201 4,074 862,127 99.5 899,297
Ethnicity (broad categories) Black 11,186 294 10,892 97.4 14,917
Mixed 5,572 91 5,481 98.4 6,643
Other 13,146 210 12,936 98.4 16,142
South Asian 50,533 833 49,700 98.4 57,064
Unknown 108,815 728 108,087 99.3 123,746
White 1,819,538 8,113 1,811,425 99.6 1,879,472
ethnicity 16 groups African 3,808 140 3,668 96.3 5,390
Bangladeshi or British Bangladeshi 1,624 35 1,589 97.8 1,890
Caribbean 5,320 112 5,208 97.9 6,860
Chinese 3,451 35 3,416 99.0 4,347
Other 9,674 175 9,499 98.2 11,781
Other Asian 10,017 133 9,884 98.7 11,627
British or Mixed British 1,730,127 7,357 1,722,770 99.6 1,779,491
Indian or British Indian 28,742 322 28,420 98.9 31,479
Irish 14,483 98 14,385 99.3 15,421
Other Black 2,058 49 2,009 97.6 2,667
Other White 74,928 658 74,270 99.1 84,560
Other mixed 2,240 28 2,212 98.8 2,604
Pakistani or British Pakistani 10,157 343 9,814 96.6 12,075
Unknown 108,829 728 108,101 99.3 123,753
White + Asian 1,267 14 1,253 98.9 1,428
White + Black African 868 28 840 96.8 1,106
White + Black Caribbean 1,204 21 1,183 98.3 1,512
Index of Multiple Deprivation (quintiles) 1 Most deprived 255,535 2,317 253,218 99.1 273,847
2 335,531 2,142 333,389 99.4 354,039
3 449,603 2,233 447,370 99.5 468,566
4 467,159 1,925 465,234 99.6 484,477
5 Least deprived 462,035 1,421 460,614 99.7 475,671
Unknown 38,927 245 38,682 99.4 41,384
BMI 30+ 504,434 2,282 502,152 99.5 519,036
under 30 1,504,356 8,001 1,496,355 99.5 1,578,948
Housebound no 1,969,422 9,576 1,959,846 99.5 2,056,908
yes 39,368 700 38,668 98.2 41,076
Chronic cardiac disease no 1,641,080 8,239 1,632,841 99.5 1,718,969
yes 367,710 2,037 365,673 99.4 379,015
Current COPD no 1,816,787 9,086 1,807,701 99.5 1,900,339
yes 192,003 1,197 190,806 99.4 197,645
Dialysis no 2,004,709 10,255 1,994,454 99.5 2,093,784
yes 4,081 28 4,053 99.3 4,200
DMARDs no 1,936,319 9,954 1,926,365 99.5 2,023,924
yes 72,471 329 72,142 99.5 74,060
Dementia no 1,967,329 9,870 1,957,459 99.5 2,054,997
yes 41,461 413 41,048 99.0 42,994
Psychosis, schizophrenia, or bipolar no 1,989,932 9,961 1,979,971 99.5 2,077,558
yes 18,858 322 18,536 98.3 20,426
Learning disability no 2,005,948 10,234 1,995,714 99.5 2,095,009
yes 2,842 42 2,800 98.5 2,982
SSRI (last 12 months) no 1,904,952 9,695 1,895,257 99.5 1,991,878
yes 103,845 595 103,250 99.4 106,106
Chemo or radiotherapy no 1,938,510 9,982 1,928,528 99.5 2,026,094
yes 70,280 301 69,979 99.6 71,890
Cancer (lung) no 1,995,742 10,199 1,985,543 99.5 2,084,621
yes 13,048 77 12,971 99.4 13,370
Cancer (excluding lung/haem) no 1,719,375 9,114 1,710,261 99.5 1,801,317
yes 289,422 1,169 288,253 99.6 296,674
Cancer (haematological) no 1,978,081 10,129 1,967,952 99.5 2,066,477
yes 30,709 154 30,555 99.5 31,507
brand of first dose Moderna 462 70 392 84.8 1,036
Oxford-AZ 1,212,666 7,504 1,205,162 99.4 1,212,876
Pfizer 794,192 2,660 791,532 99.7 803,075
Unknown 1,470 49 1,421 96.7 1,484

Footnotes:

  • Patient counts rounded to the nearest 7
  • Only persons who are currently registered and had their fist dose at least 14 weeks ago are included in the 'due' group.
  • Population excludes those known to live in an elderly care home, based upon clinical coding.
  • SSRIs group excludes individuals with Psychosis/ schizophrenia/bipolar, LD, or Dementia.

Second Doses Overdue Among 70-79 Population

Second doses which have not been given at least 14 weeks since the first dose

Error bars indicate possible error caused by rounding

Back to top

Cumulative second dose vaccination figures among care home population

Please refer to footnotes below table for information.

Second Doses due at 24 Nov (n) Second doses overdue (n) Second doses given (n) Second doses given (% of due) Total population
Category Group
overall overall 103,810 1,421 102,389 98.6 109,900
Sex F 72,828 882 71,946 98.8 76,853
M 30,982 539 30,443 98.3 33,054
Age band 65-69 5,691 133 5,558 97.7 6,160
70-74 8,988 182 8,806 98.0 9,632
75-79 12,845 217 12,628 98.3 13,671
80-84 18,508 259 18,249 98.6 19,628
85-89 24,437 301 24,136 98.8 25,851
90+ 33,348 336 33,012 99.0 34,958
Ethnicity (broad categories) Black 581 21 560 96.4 707
Mixed 301 7 294 97.7 322
Other 476 7 469 98.5 511
South Asian 917 28 889 96.9 1,015
Unknown 2,142 28 2,114 98.7 2,429
White 99,393 1,337 98,056 98.7 104,909
Dementia no 47,075 714 46,361 98.5 50,498
yes 56,735 714 56,021 98.7 59,402
brand of first dose Moderna 0 0 0 NaN 35
Oxford-AZ 74,326 1,204 73,122 98.4 74,382
Pfizer 29,330 224 29,106 99.2 31,752
Unknown 147 0 147 100.0 154

Footnotes:

  • Patient counts rounded to the nearest 7
  • Only persons who are currently registered and had their fist dose at least 14 weeks ago are included in the 'due' group.
  • Population includes those known to live in an elderly care home, based upon clinical coding.

Second Doses Overdue Among Care Home Population

Second doses which have not been given at least 14 weeks since the first dose

Error bars indicate possible error caused by rounding

Back to top

Cumulative second dose vaccination figures among shielding (aged 16-69) population

Please refer to footnotes below table for information.

Second Doses due at 24 Nov (n) Second doses overdue (n) Second doses given (n) Second doses given (% of due) Total population
Category Group
overall overall 745,381 17,003 728,378 97.7 826,777
newly shielded since feb 15 no 450,317 8,043 442,274 98.2 486,829
yes 295,064 8,960 286,104 97.0 339,941
Sex F 418,362 9,954 408,408 97.6 465,885
M 327,005 7,042 319,963 97.8 360,878
Age band 16-29 53,634 2,597 51,037 95.2 66,878
30-39 105,385 4,067 101,318 96.1 125,972
40-49 147,371 3,969 143,402 97.3 165,564
50-59 212,261 3,892 208,369 98.2 229,544
60-69 226,716 2,471 224,245 98.9 238,812
Ethnicity (broad categories) Black 33,411 1,372 32,039 95.9 44,695
Mixed 11,340 427 10,913 96.2 14,357
Other 14,714 434 14,280 97.1 18,158
South Asian 94,276 3,017 91,259 96.8 107,947
Unknown 23,261 441 22,820 98.1 26,509
White 568,365 11,312 557,053 98.0 615,097
Index of Multiple Deprivation (quintiles) 1 Most deprived 208,992 7,000 201,992 96.7 241,556
2 166,404 4,109 162,295 97.5 186,165
3 143,920 2,653 141,267 98.2 157,332
4 115,395 1,778 113,617 98.5 123,837
5 Least deprived 91,224 987 90,237 98.9 96,229
Unknown 19,439 469 18,970 97.6 21,644
Learning disability no 720,349 16,443 703,906 97.7 799,848
yes 25,018 553 24,465 97.8 26,915
brand of first dose Moderna 1,568 224 1,344 85.7 2,058
Oxford-AZ 473,788 11,620 462,168 97.5 474,026
Pfizer 269,493 5,124 264,369 98.1 278,698
Unknown 518 28 490 94.6 518

Footnotes:

  • Patient counts rounded to the nearest 7
  • Only persons who are currently registered and had their fist dose at least 14 weeks ago are included in the 'due' group.
  • Population excludes those over 65 known to live in an elderly care home, based upon clinical coding.

Second Doses Overdue Among Shielding (Aged 16-69) Population

Second doses which have not been given at least 14 weeks since the first dose

Error bars indicate possible error caused by rounding

Back to top

Cumulative second dose vaccination figures among 65-69 population

Please refer to footnotes below table for information.

Second Doses due at 24 Nov (n) Second doses overdue (n) Second doses given (n) Second doses given (% of due) Total population
Category Group
overall overall 1,012,291 7,868 1,004,423 99.2 1,087,107
Sex F 520,695 4,165 516,530 99.2 556,290
M 491,589 3,703 487,886 99.2 530,803
Ethnicity (broad categories) Black 8,463 252 8,211 97.0 11,585
Mixed 4,186 77 4,109 98.2 5,180
Other 9,737 168 9,569 98.3 12,607
South Asian 39,592 756 38,836 98.1 45,416
Unknown 73,479 721 72,758 99.0 87,507
White 876,827 5,901 870,926 99.3 924,798
ethnicity 16 groups African 3,304 119 3,185 96.4 4,613
Bangladeshi or British Bangladeshi 1,659 21 1,638 98.7 1,869
Caribbean 3,381 84 3,297 97.5 4,676
Chinese 3,094 35 3,059 98.9 4,046
Other 6,643 133 6,510 98.0 8,561
Other Asian 7,343 140 7,203 98.1 8,603
British or Mixed British 829,157 5,215 823,942 99.4 865,480
Indian or British Indian 21,322 273 21,049 98.7 23,765
Irish 6,132 63 6,069 99.0 6,748
Other Black 1,778 49 1,729 97.2 2,296
Other White 41,538 616 40,922 98.5 52,570
Other mixed 1,631 21 1,610 98.7 2,016
Pakistani or British Pakistani 9,268 315 8,953 96.6 11,186
Unknown 73,479 728 72,751 99.0 87,507
White + Asian 938 14 924 98.5 1,071
White + Black African 700 14 686 98.0 931
White + Black Caribbean 924 28 896 97.0 1,169
Index of Multiple Deprivation (quintiles) 1 Most deprived 138,383 1,904 136,479 98.6 155,036
2 174,979 1,631 173,348 99.1 191,016
3 224,784 1,659 223,125 99.3 240,674
4 229,418 1,400 228,018 99.4 243,019
5 Least deprived 223,160 1,071 222,089 99.5 233,744
Unknown 21,560 196 21,364 99.1 23,604
BMI 30+ 260,351 1,764 258,587 99.3 272,314
under 30 751,933 6,104 745,829 99.2 814,786
Housebound no 1,007,797 7,714 1,000,083 99.2 1,082,221
yes 4,480 147 4,333 96.7 4,879
Chronic cardiac disease no 903,763 6,979 896,784 99.2 972,951
yes 108,514 882 107,632 99.2 114,142
Current COPD no 973,658 7,455 966,203 99.2 1,046,311
yes 38,626 413 38,213 98.9 40,789
DMARDs no 992,488 7,742 984,746 99.2 1,066,562
yes 19,796 126 19,670 99.4 20,531
Dementia no 1,006,747 7,770 998,977 99.2 1,081,227
yes 5,530 91 5,439 98.4 5,866
Psychosis, schizophrenia, or bipolar no 1,001,875 7,637 994,238 99.2 1,075,333
yes 10,409 231 10,178 97.8 11,767
Learning disability no 1,009,953 7,819 1,002,134 99.2 1,084,580
yes 2,331 49 2,282 97.9 2,513
SSRI (last 12 months) no 951,853 7,329 944,524 99.2 1,024,464
yes 60,424 532 59,892 99.1 62,629
Chemo or radiotherapy no 992,817 7,763 985,054 99.2 1,066,891
yes 19,460 98 19,362 99.5 20,209
Cancer (lung) no 1,010,401 7,854 1,002,547 99.2 1,085,112
yes 1,883 14 1,869 99.3 1,981
Cancer (excluding lung/haem) no 925,358 7,371 917,987 99.2 996,590
yes 86,926 497 86,429 99.4 90,510
Cancer (haematological) no 1,008,714 7,840 1,000,874 99.2 1,083,348
yes 3,570 28 3,542 99.2 3,752
brand of first dose Moderna 483 63 420 87.0 1,183
Oxford-AZ 674,849 5,943 668,906 99.1 675,010
Pfizer 336,182 1,806 334,376 99.5 341,957
Unknown 770 49 721 93.6 784

Footnotes:

  • Patient counts rounded to the nearest 7
  • Only persons who are currently registered and had their fist dose at least 14 weeks ago are included in the 'due' group.
  • Population excludes those known to live in an elderly care home, based upon clinical coding.
  • Population excludes those who are shielding.
  • SSRIs group excludes individuals with Psychosis/ schizophrenia/bipolar, LD, or Dementia.

Second Doses Overdue Among 65-69 Population

Second doses which have not been given at least 14 weeks since the first dose

Error bars indicate possible error caused by rounding

Back to top

Cumulative second dose vaccination figures among Learning Disabilities (aged 16-64) population

Please refer to footnotes below table for information.

Second Doses due at 24 Nov (n) Second doses overdue (n) Second doses given (n) Second doses given (% of due) Total population
Category Group
overall overall 72,471 2,716 69,755 96.3 84,945
Sex F 28,056 945 27,111 96.6 32,074
M 44,415 1,778 42,637 96.0 52,864
Age band 16-17 2,786 245 2,541 91.2 4,795
18-29 25,074 1,127 23,947 95.5 30,604
30-34 9,485 413 9,072 95.6 11,102
35-39 7,084 245 6,839 96.5 8,064
40-44 5,677 168 5,509 97.0 6,293
45-49 5,572 161 5,411 97.1 6,076
50-54 6,076 140 5,936 97.7 6,545
55-59 6,055 133 5,922 97.8 6,510
60-64 4,662 84 4,578 98.2 4,963
Ethnicity (broad categories) Black 882 56 826 93.7 1,428
Mixed 812 42 770 94.8 1,155
Other 546 21 525 96.2 763
South Asian 3,703 217 3,486 94.1 4,935
Unknown 4,984 147 4,837 97.1 5,964
White 61,544 2,233 59,311 96.4 70,693
brand of first dose Moderna 371 56 315 84.9 420
Oxford-AZ 49,434 1,638 47,796 96.7 49,469
Pfizer 22,617 1,015 21,602 95.5 24,262
Unknown 42 0 42 100.0 42

Footnotes:

  • Patient counts rounded to the nearest 7
  • Only persons who are currently registered and had their fist dose at least 14 weeks ago are included in the 'due' group.
  • Population excludes those who are shielding.

Second Doses Overdue Among People With Learning Disabilities (Aged 16-64)

Second doses which have not been given at least 14 weeks since the first dose

Error bars indicate possible error caused by rounding

Back to top

Cumulative second dose vaccination figures among 60-64 population

Please refer to footnotes below table for information.

Second Doses due at 24 Nov (n) Second doses overdue (n) Second doses given (n) Second doses given (% of due) Total population
Category Group
overall overall 1,192,926 13,356 1,179,570 98.9 1,305,633
Sex F 601,230 6,566 594,664 98.9 650,671
M 591,689 6,797 584,892 98.9 654,955
Ethnicity (broad categories) Black 14,553 497 14,056 96.6 20,580
Mixed 6,636 175 6,461 97.4 8,386
Other 13,090 294 12,796 97.8 17,339
South Asian 46,879 945 45,934 98.0 54,257
Unknown 101,402 1,246 100,156 98.8 123,347
White 1,010,359 10,199 1,000,160 99.0 1,081,710
ethnicity 16 groups African 5,810 203 5,607 96.5 8,015
Bangladeshi or British Bangladeshi 2,072 42 2,030 98.0 2,338
Caribbean 5,474 189 5,285 96.5 8,106
Chinese 4,011 77 3,934 98.1 5,159
Other 9,100 224 8,876 97.5 12,201
Other Asian 9,933 175 9,758 98.2 11,746
British or Mixed British 949,634 9,016 940,618 99.1 1,001,910
Indian or British Indian 24,220 378 23,842 98.4 27,328
Irish 6,034 91 5,943 98.5 6,783
Other Black 3,269 105 3,164 96.8 4,466
Other White 54,670 1,099 53,571 98.0 72,989
Other mixed 2,513 63 2,450 97.5 3,199
Pakistani or British Pakistani 10,654 350 10,304 96.7 12,845
Unknown 101,409 1,246 100,163 98.8 123,361
White + Asian 1,344 21 1,323 98.4 1,540
White + Black African 1,225 35 1,190 97.1 1,575
White + Black Caribbean 1,561 63 1,498 96.0 2,079
Index of Multiple Deprivation (quintiles) 1 Most deprived 174,027 3,318 170,709 98.1 201,453
2 211,554 2,849 208,705 98.7 236,180
3 261,345 2,688 258,657 99.0 284,599
4 265,342 2,310 263,032 99.1 285,138
5 Least deprived 254,814 1,799 253,015 99.3 269,556
Unknown 25,837 392 25,445 98.5 28,693
BMI 30+ 301,231 2,863 298,368 99.0 318,367
under 30 891,681 10,486 881,195 98.8 987,259
Chronic cardiac disease no 1,101,499 12,362 1,089,137 98.9 1,208,221
yes 91,420 1,001 90,419 98.9 97,405
Current COPD no 1,159,963 12,796 1,147,167 98.9 1,270,304
yes 32,949 553 32,396 98.3 35,322
DMARDs no 1,172,255 13,188 1,159,067 98.9 1,283,926
yes 20,664 168 20,496 99.2 21,700
Dementia no 1,189,335 13,279 1,176,056 98.9 1,301,790
yes 3,577 77 3,500 97.8 3,829
Psychosis, schizophrenia, or bipolar no 1,179,745 12,950 1,166,795 98.9 1,290,415
yes 13,174 413 12,761 96.9 15,204
SSRI (last 12 months) no 1,110,914 12,292 1,098,622 98.9 1,219,561
yes 81,998 1,057 80,941 98.7 86,065
Chemo or radiotherapy no 1,175,202 13,209 1,161,993 98.9 1,287,097
yes 17,717 154 17,563 99.1 18,529
Cancer (lung) no 1,191,666 13,335 1,178,331 98.9 1,304,275
yes 1,253 21 1,232 98.3 1,351
Cancer (excluding lung/haem) no 1,121,316 12,761 1,108,555 98.9 1,230,278
yes 71,603 595 71,008 99.2 75,348
Cancer (haematological) no 1,189,706 13,328 1,176,378 98.9 1,302,210
yes 3,213 28 3,185 99.1 3,416
brand of first dose Moderna 973 119 854 87.8 1,778
Oxford-AZ 884,345 10,591 873,754 98.8 884,604
Pfizer 306,803 2,569 304,234 99.2 313,236
Unknown 791 70 721 91.2 812

Footnotes:

  • Patient counts rounded to the nearest 7
  • Only persons who are currently registered and had their fist dose at least 14 weeks ago are included in the 'due' group.
  • Population excludes those who are shielding.
  • SSRIs group excludes individuals with Psychosis/ schizophrenia/bipolar, LD, or Dementia.

Second Doses Overdue Among 60-64 Population

Second doses which have not been given at least 14 weeks since the first dose

Error bars indicate possible error caused by rounding

Back to top

Cumulative second dose vaccination figures among 55-59 population

Please refer to footnotes below table for information.

Second Doses due at 24 Nov (n) Second doses overdue (n) Second doses given (n) Second doses given (% of due) Total population
Category Group
overall overall 1,372,301 20,132 1,352,169 98.5 1,534,799
Sex F 687,876 9,331 678,545 98.6 754,838
M 684,411 10,794 673,617 98.4 779,954
Ethnicity (broad categories) Black 22,526 861 21,665 96.2 32,683
Mixed 9,954 301 9,653 97.0 12,936
Other 17,353 427 16,926 97.5 23,646
South Asian 53,158 1,246 51,912 97.7 62,440
Unknown 121,394 1,932 119,462 98.4 152,859
White 1,147,909 15,358 1,132,551 98.7 1,250,228
ethnicity 16 groups African 9,758 350 9,408 96.4 13,678
Bangladeshi or British Bangladeshi 2,758 56 2,702 98.0 3,122
Caribbean 7,140 322 6,818 95.5 11,088
Chinese 5,124 105 5,019 98.0 6,713
Other 12,236 329 11,907 97.3 16,933
Other Asian 12,957 280 12,677 97.8 15,610
British or Mixed British 1,072,708 13,657 1,059,051 98.7 1,147,741
Indian or British Indian 25,858 483 25,375 98.1 29,393
Irish 6,965 133 6,832 98.1 8,078
Other Black 5,635 189 5,446 96.6 7,924
Other White 68,201 1,561 66,640 97.7 94,381
Other mixed 3,542 98 3,444 97.2 4,606
Pakistani or British Pakistani 11,592 427 11,165 96.3 14,315
Unknown 121,408 1,932 119,476 98.4 152,866
White + Asian 2,037 42 1,995 97.9 2,415
White + Black African 1,855 70 1,785 96.2 2,485
White + Black Caribbean 2,513 91 2,422 96.4 3,430
Index of Multiple Deprivation (quintiles) 1 Most deprived 208,390 5,222 203,168 97.5 249,039
2 244,601 4,319 240,282 98.2 280,357
3 297,059 4,032 293,027 98.6 330,281
4 301,357 3,388 297,969 98.9 329,441
5 Least deprived 291,662 2,632 289,030 99.1 312,760
Unknown 29,218 532 28,686 98.2 32,907
BMI 30+ 333,144 3,969 329,175 98.8 356,419
under 30 1,039,143 16,156 1,022,987 98.4 1,178,373
Chronic cardiac disease no 1,303,512 19,005 1,284,507 98.5 1,460,305
yes 68,782 1,127 67,655 98.4 74,480
Current COPD no 1,346,653 19,537 1,327,116 98.5 1,506,638
yes 25,634 588 25,046 97.7 28,154
DMARDs no 1,351,588 19,915 1,331,673 98.5 1,512,819
yes 20,699 210 20,489 99.0 21,973
Psychosis, schizophrenia, or bipolar no 1,356,089 19,523 1,336,566 98.6 1,515,521
yes 16,205 609 15,596 96.2 19,271
SSRI (last 12 months) no 1,268,820 18,529 1,250,291 98.5 1,425,256
yes 103,467 1,596 101,871 98.5 109,536
brand of first dose Moderna 1,806 266 1,540 85.3 2,597
Oxford-AZ 1,076,558 15,953 1,060,605 98.5 1,076,992
Pfizer 293,181 3,822 289,359 98.7 301,616
Unknown 742 84 658 88.7 756

Footnotes:

  • Patient counts rounded to the nearest 7
  • Only persons who are currently registered and had their fist dose at least 14 weeks ago are included in the 'due' group.
  • Population excludes those who are shielding.
  • SSRIs group excludes individuals with Psychosis/ schizophrenia/bipolar, LD, or Dementia.

Second Doses Overdue Among 55-59 Population

Second doses which have not been given at least 14 weeks since the first dose

Error bars indicate possible error caused by rounding

Back to top

Cumulative second dose vaccination figures among 50-54 population

Please refer to footnotes below table for information.

Second Doses due at 24 Nov (n) Second doses overdue (n) Second doses given (n) Second doses given (% of due) Total population
Category Group
overall overall 1,372,203 26,138 1,346,065 98.1 1,578,773
Sex F 689,878 11,641 678,237 98.3 770,231
M 682,318 14,497 667,821 97.9 808,528
Ethnicity (broad categories) Black 25,809 1,078 24,731 95.8 38,346
Mixed 11,830 378 11,452 96.8 15,883
Other 21,875 651 21,224 97.0 30,821
South Asian 74,403 2,121 72,282 97.1 89,740
Unknown 128,996 2,450 126,546 98.1 167,265
White 1,109,276 19,460 1,089,816 98.2 1,236,704
ethnicity 16 groups African 14,301 574 13,727 96.0 20,335
Bangladeshi or British Bangladeshi 4,571 105 4,466 97.7 5,201
Caribbean 5,537 252 5,285 95.4 9,275
Chinese 5,803 140 5,663 97.6 7,756
Other 16,072 511 15,561 96.8 23,058
Other Asian 18,018 462 17,556 97.4 22,162
British or Mixed British 1,020,831 17,115 1,003,716 98.3 1,108,786
Indian or British Indian 31,990 686 31,304 97.9 37,142
Irish 6,783 196 6,587 97.1 8,106
Other Black 5,964 245 5,719 95.9 8,736
Other White 81,655 2,149 79,506 97.4 119,812
Other mixed 4,305 126 4,179 97.1 5,901
Pakistani or British Pakistani 19,824 861 18,963 95.7 25,242
Unknown 129,010 2,457 126,553 98.1 167,272
White + Asian 2,576 70 2,506 97.3 3,094
White + Black African 2,471 91 2,380 96.3 3,409
White + Black Caribbean 2,485 98 2,387 96.1 3,479
Index of Multiple Deprivation (quintiles) 1 Most deprived 220,122 7,371 212,751 96.7 275,443
2 249,214 5,845 243,369 97.7 295,834
3 290,598 5,033 285,565 98.3 331,919
4 294,539 4,179 290,360 98.6 328,517
5 Least deprived 287,518 3,059 284,459 98.9 312,354
Unknown 30,198 651 29,547 97.8 34,692
BMI 30+ 318,444 4,942 313,502 98.4 345,814
under 30 1,053,745 21,196 1,032,549 98.0 1,232,945
Chronic cardiac disease no 1,327,802 25,144 1,302,658 98.1 1,529,486
yes 44,387 987 43,400 97.8 49,266
Current COPD no 1,355,536 25,606 1,329,930 98.1 1,559,992
yes 16,653 532 16,121 96.8 18,767
DMARDs no 1,354,255 25,893 1,328,362 98.1 1,559,488
yes 17,934 238 17,696 98.7 19,271
Psychosis, schizophrenia, or bipolar no 1,355,830 25,333 1,330,497 98.1 1,558,641
yes 16,359 805 15,554 95.1 20,118
SSRI (last 12 months) no 1,262,534 23,961 1,238,573 98.1 1,461,467
yes 109,655 2,170 107,485 98.0 117,285
brand of first dose Moderna 5,775 378 5,397 93.5 6,678
Oxford-AZ 1,099,630 20,223 1,079,407 98.2 1,100,183
Pfizer 265,979 5,425 260,554 98.0 277,004
Unknown 805 112 693 86.1 826

Footnotes:

  • Patient counts rounded to the nearest 7
  • Only persons who are currently registered and had their fist dose at least 14 weeks ago are included in the 'due' group.
  • Population excludes those who are shielding.
  • SSRIs group excludes individuals with Psychosis/ schizophrenia/bipolar, LD, or Dementia.

Second Doses Overdue Among 50-54 Population

Second doses which have not been given at least 14 weeks since the first dose

Error bars indicate possible error caused by rounding

Back to top

Cumulative second dose vaccination figures among 40-49 population

Please refer to footnotes below table for information.

Second Doses due at 24 Nov (n) Second doses overdue (n) Second doses given (n) Second doses given (% of due) Total population
Category Group
overall overall 2,351,895 75,187 2,276,708 96.8 2,984,037
Sex F 1,191,736 32,123 1,159,613 97.3 1,426,376
M 1,160,124 43,064 1,117,060 96.3 1,557,605
Ethnicity (broad categories) Black 56,847 3,101 53,746 94.5 92,379
Mixed 28,910 1,288 27,622 95.5 43,246
Other 59,276 2,387 56,889 96.0 92,820
South Asian 205,828 8,225 197,603 96.0 273,847
Unknown 204,246 6,643 197,603 96.7 304,010
White 1,796,746 53,543 1,743,203 97.0 2,177,686
ethnicity 16 groups African 38,178 1,981 36,197 94.8 58,765
Bangladeshi or British Bangladeshi 15,442 588 14,854 96.2 19,145
Caribbean 7,021 441 6,580 93.7 14,679
Chinese 15,043 378 14,665 97.5 22,638
Other 44,233 2,009 42,224 95.5 70,175
Other Asian 48,034 1,673 46,361 96.5 64,897
British or Mixed British 1,574,524 45,766 1,528,758 97.1 1,799,483
Indian or British Indian 87,626 2,562 85,064 97.1 113,687
Irish 11,137 385 10,752 96.5 14,910
Other Black 11,662 686 10,976 94.1 18,949
Other White 211,001 7,378 203,623 96.5 363,181
Other mixed 11,193 483 10,710 95.7 17,227
Pakistani or British Pakistani 54,733 3,402 51,331 93.8 76,132
Unknown 204,316 6,650 197,666 96.7 304,087
White + Asian 6,468 238 6,230 96.3 8,610
White + Black African 6,748 329 6,419 95.1 9,996
White + Black Caribbean 4,508 245 4,263 94.6 7,427
Index of Multiple Deprivation (quintiles) 1 Most deprived 403,200 22,148 381,052 94.5 579,544
2 437,101 16,702 420,399 96.2 584,045
3 485,933 14,112 471,821 97.1 612,395
4 484,225 11,459 472,766 97.6 583,219
5 Least deprived 476,560 8,624 467,936 98.2 545,909
Unknown 64,848 2,149 62,699 96.7 78,869
brand of first dose Moderna 81,536 2,912 78,624 96.4 84,077
Oxford-AZ 1,660,323 45,878 1,614,445 97.2 1,662,031
Pfizer 608,321 26,117 582,204 95.7 645,750
Unknown 1,680 294 1,386 82.5 1,757

Footnotes:

  • Patient counts rounded to the nearest 7
  • Only persons who are currently registered and had their fist dose at least 14 weeks ago are included in the 'due' group.

Second Doses Overdue Among 40-49 Population

Second doses which have not been given at least 14 weeks since the first dose

Error bars indicate possible error caused by rounding

Back to top

Cumulative second dose vaccination figures among 30-39 population

Please refer to footnotes below table for information.

Second Doses due at 24 Nov (n) Second doses overdue (n) Second doses given (n) Second doses given (% of due) Total population
Category Group
overall overall 2,271,444 119,742 2,151,702 94.7 3,372,537
Sex F 1,167,376 52,542 1,114,834 95.5 1,632,841
M 1,103,998 67,200 1,036,798 93.9 1,739,605
Ethnicity (broad categories) Black 45,080 3,710 41,370 91.8 97,531
Mixed 34,139 2,247 31,892 93.4 62,748
Other 63,455 3,703 59,752 94.2 123,053
South Asian 215,089 12,789 202,300 94.1 341,698
Unknown 196,525 10,661 185,864 94.6 329,784
White 1,717,086 86,625 1,630,461 95.0 2,417,632
ethnicity 16 groups African 30,723 2,422 28,301 92.1 61,159
Bangladeshi or British Bangladeshi 15,323 959 14,364 93.7 22,631
Caribbean 5,348 476 4,872 91.1 16,079
Chinese 15,694 525 15,169 96.7 31,731
Other 47,747 3,178 44,569 93.3 91,315
Other Asian 47,873 2,779 45,094 94.2 77,490
British or Mixed British 1,477,280 73,787 1,403,493 95.0 1,890,497
Indian or British Indian 94,885 4,382 90,503 95.4 145,537
Irish 10,157 525 9,632 94.8 16,821
Other Black 9,016 812 8,204 91.0 20,307
Other White 229,649 12,320 217,329 94.6 510,307
Other mixed 13,930 840 13,090 94.0 25,662
Pakistani or British Pakistani 57,015 4,676 52,339 91.8 96,047
Unknown 196,525 10,647 185,878 94.6 329,784
White + Asian 7,910 476 7,434 94.0 12,131
White + Black African 5,908 392 5,516 93.4 10,913
White + Black Caribbean 6,405 546 5,859 91.5 14,028
Index of Multiple Deprivation (quintiles) 1 Most deprived 434,805 35,119 399,686 91.9 756,462
2 458,346 27,160 431,186 94.1 724,990
3 471,793 22,603 449,190 95.2 688,618
4 434,189 17,843 416,346 95.9 593,663
5 Least deprived 374,668 12,677 361,991 96.6 480,403
Unknown 97,573 4,340 93,233 95.6 128,310
brand of first dose Moderna 136,171 9,338 126,833 93.1 142,464
Oxford-AZ 545,020 22,344 522,676 95.9 545,615
Pfizer 1,588,258 87,605 1,500,653 94.5 1,684,753
Unknown 1,925 448 1,477 76.7 2,002

Footnotes:

  • Patient counts rounded to the nearest 7
  • Only persons who are currently registered and had their fist dose at least 14 weeks ago are included in the 'due' group.

Second Doses Overdue Among 30-39 Population

Second doses which have not been given at least 14 weeks since the first dose

Error bars indicate possible error caused by rounding

Back to top

Cumulative second dose vaccination figures among 18-29 population

Please refer to footnotes below table for information.

Second Doses due at 24 Nov (n) Second doses overdue (n) Second doses given (n) Second doses given (% of due) Total population
Category Group
overall overall 2,175,810 173,999 2,001,811 92.0 3,490,249
Sex F 1,108,954 74,893 1,034,061 93.2 1,725,500
M 1,066,667 99,092 967,575 90.7 1,764,476
Ethnicity (broad categories) Black 36,568 5,005 31,563 86.3 103,383
Mixed 37,555 3,857 33,698 89.7 77,280
Other 53,172 4,809 48,363 91.0 144,368
South Asian 168,217 15,337 152,880 90.9 303,177
Unknown 333,585 24,227 309,358 92.7 537,138
White 1,546,531 120,750 1,425,781 92.2 2,324,630
ethnicity 16 groups African 23,310 3,269 20,041 86.0 62,202
Bangladeshi or British Bangladeshi 13,678 1,330 12,348 90.3 23,184
Caribbean 4,823 595 4,228 87.7 16,555
Chinese 16,744 889 15,855 94.7 59,535
Other 36,442 3,913 32,529 89.3 84,854
Other Asian 37,457 3,339 34,118 91.1 70,091
British or Mixed British 1,397,144 106,764 1,290,380 92.4 1,943,452
Indian or British Indian 71,932 5,383 66,549 92.5 112,644
Irish 7,133 644 6,489 91.0 12,845
Other Black 8,428 1,127 7,301 86.6 24,640
Other White 142,226 13,335 128,891 90.6 368,256
Other mixed 13,888 1,379 12,509 90.1 29,057
Pakistani or British Pakistani 45,157 5,292 39,865 88.3 97,265
Unknown 333,571 24,213 309,358 92.7 537,166
White + Asian 10,164 847 9,317 91.7 16,933
White + Black African 5,502 672 4,830 87.8 12,551
White + Black Caribbean 8,008 959 7,049 88.0 18,746
Index of Multiple Deprivation (quintiles) 1 Most deprived 403,879 46,487 357,392 88.5 791,168
2 439,117 38,626 400,491 91.2 748,363
3 456,694 34,342 422,352 92.5 707,315
4 420,504 27,629 392,875 93.4 611,961
5 Least deprived 377,188 21,553 355,635 94.3 513,289
Unknown 78,239 5,341 72,898 93.2 117,880
brand of first dose Moderna 156,247 16,380 139,867 89.5 168,042
Oxford-AZ 345,485 17,157 328,328 95.0 346,010
Pfizer 1,672,286 139,895 1,532,391 91.6 1,845,277
Unknown 1,603 546 1,057 65.9 1,680

Footnotes:

  • Patient counts rounded to the nearest 7
  • Only persons who are currently registered and had their fist dose at least 14 weeks ago are included in the 'due' group.

Second Doses Overdue Among 18-29 Population

Second doses which have not been given at least 14 weeks since the first dose

Error bars indicate possible error caused by rounding

Summary

Second Doses due at 24 Nov (n) Second doses given (% of due) Second doses given (n) Second doses overdue (n) Total population
80+ 1,061,683 99.5 1,055,922 5,761 1,102,570
70-79 2,008,797 99.5 1,998,514 10,283 2,097,998
care home 103,810 98.6 102,389 1,421 109,900
shielding (aged 16-69) 745,381 97.7 728,378 17,003 826,777
65-69 1,012,291 99.2 1,004,423 7,868 1,087,107
LD (aged 16-64) 72,471 96.3 69,755 2,716 84,945
60-64 1,192,926 98.9 1,179,570 13,356 1,305,633
55-59 1,372,301 98.5 1,352,169 20,132 1,534,799
50-54 1,372,203 98.1 1,346,065 26,138 1,578,773
40-49 2,351,895 96.8 2,276,708 75,187 2,984,037
30-39 2,271,444 94.7 2,151,702 119,742 3,372,537
18-29 2,175,810 92.0 2,001,811 173,999 3,490,249

Vaccine Coverage - Second Doses

Description
Weekly* report on COVID-19 vaccination coverage in England focussing on second doses which are due (i.e. where first dose was recorded at least 14 weeks ago). * please note, updates will occur most weeks but not all.
Contact
Get in touch and tell us how you use this report or new features you'd like to see: [email protected]
First published
02 Jul 2021
Last updated
30 Nov 2021

http://doi.org/10.53764/rpt.cd7cf36769

Links

OpenSAFELY COVID Vaccine coverage report: Second doses

OpenSAFELY is a new secure analytics platform for electronic patient records built on behalf of NHS England to deliver urgent academic and operational research during the pandemic.

This is an extension of our regular weekly report on COVID-19 vaccination coverage in England using data from 40% of general practices that use TPP electronic health record software. The data requires careful interpretation and there are a number of caveats. Please read the full detail about our methods and discussion of our earlier results (as of January 13th) in our preprint paper available here.

The full analytical methods behind the latest results in this report are available here.

Second doses

Please note This report is intended to highlight any differences between subgroups of priority cohorts in receiving second doses, only including those which are due (i.e. where at least 14 weeks has passed since the first dose). It is therefore NOT a comprehensive view of all second doses given to date - to see these figures please refer to the main report.

New: now includes everyone over 18 and a breakdown by brand of first dose

Report last updated 30 Nov 2021

Second dose vaccinations included up to 24 Nov 2021 inclusive

Only persons who had their first dose between the start of the campaign (7 Dec 2020) and 14 weeks ago (18 Aug 2021) are included in the 'due' group.

Contents

Cumulative second dose vaccination figures among:

SUMMARY

Group definitions

  • As of 29 Nov 2021, patient age is calculated at 31 Aug 2021 (previously 31 March 2021), in line with national reporting.
  • The care home group is defined based on patients (aged 65+) having one of these codes.
  • The shielding group is defined based on patients (aged 16-69) having one of these codes provided it was not superceded by one of these codes.
  • The LD (learning disability) group is defined based on patients (aged 16-64) having one of these codes and excludes people who are shielding.
  • Patients are counted in their highest risk category only; e.g. a 65-year-old who is shielding is only counted in the shielding group, not in the 65-69 group.
  • The housebound group is defined based on this codelist and excludes people who were later recorded as not housebound or in a care home.

Back to top

Cumulative second dose vaccination figures among 80+ population

Please refer to footnotes below table for information.

Second Doses due at 24 Nov (n) Second doses overdue (n) Second doses given (n) Second doses given (% of due) Total population
Category Group
overall overall 1,061,683 5,761 1,055,922 99.5 1,102,570
Sex F 612,514 3,738 608,776 99.4 636,706
M 449,162 2,023 447,139 99.5 465,864
Age band 80-84 562,471 2,625 559,846 99.5 582,652
85-89 334,033 1,897 332,136 99.4 346,535
90+ 165,172 1,232 163,940 99.3 173,376
Ethnicity (broad categories) Black 8,561 210 8,351 97.5 11,004
Mixed 2,786 42 2,744 98.5 3,304
Other 5,691 84 5,607 98.5 6,776
South Asian 25,186 434 24,752 98.3 28,420
Unknown 44,065 322 43,743 99.3 51,541
White 975,394 4,676 970,718 99.5 1,001,518
ethnicity 16 groups African 1,463 49 1,414 96.7 2,086
Bangladeshi or British Bangladeshi 1,106 28 1,078 97.5 1,302
Caribbean 6,027 126 5,901 97.9 7,511
Chinese 1,407 21 1,386 98.5 1,722
Other 4,277 63 4,214 98.5 5,047
Other Asian 3,808 49 3,759 98.7 4,466
British or Mixed British 926,604 4,291 922,313 99.5 949,046
Indian or British Indian 13,853 119 13,734 99.1 15,064
Irish 9,121 70 9,051 99.2 9,569
Other Black 1,071 28 1,043 97.4 1,407
Other White 39,662 322 39,340 99.2 42,896
Other mixed 1,036 7 1,029 99.3 1,176
Pakistani or British Pakistani 6,419 238 6,181 96.3 7,588
Unknown 44,086 322 43,764 99.3 51,562
White + Asian 490 7 483 98.6 546
White + Black African 280 0 280 100.0 385
White + Black Caribbean 966 14 952 98.6 1,197
Index of Multiple Deprivation (quintiles) 1 Most deprived 131,516 1,267 130,249 99.0 140,224
2 174,797 1,211 173,586 99.3 183,225
3 238,686 1,225 237,461 99.5 247,310
4 248,157 1,071 247,086 99.6 255,892
5 Least deprived 249,060 847 248,213 99.7 255,388
Unknown 19,467 140 19,327 99.3 20,531
BMI 30+ 188,657 910 187,747 99.5 193,319
under 30 873,019 4,844 868,175 99.4 909,244
Housebound no 953,022 4,340 948,682 99.5 989,765
yes 108,661 1,428 107,233 98.7 112,798
Chronic cardiac disease no 738,409 4,032 734,377 99.5 770,938
yes 323,274 1,736 321,538 99.5 331,625
Current COPD no 949,067 5,096 943,971 99.5 987,133
yes 112,609 665 111,944 99.4 115,430
Dialysis no 1,059,667 5,747 1,053,920 99.5 1,100,498
yes 2,009 14 1,995 99.3 2,065
DMARDs no 1,027,824 5,600 1,022,224 99.5 1,068,074
yes 33,859 168 33,691 99.5 34,489
Dementia no 978,726 4,914 973,812 99.5 1,016,449
yes 82,957 854 82,103 99.0 86,114
Psychosis, schizophrenia, or bipolar no 1,054,025 5,649 1,048,376 99.5 1,094,380
yes 7,651 112 7,539 98.5 8,183
Learning disability no 1,061,193 5,754 1,055,439 99.5 1,102,059
yes 483 7 476 98.6 511
SSRI (last 12 months) no 1,018,913 5,488 1,013,425 99.5 1,058,953
yes 42,763 266 42,497 99.4 43,610
Chemo or radiotherapy no 1,024,513 5,600 1,018,913 99.5 1,064,595
yes 37,170 168 37,002 99.5 37,968
Cancer (lung) no 1,054,249 5,719 1,048,530 99.5 1,094,961
yes 7,427 35 7,392 99.5 7,602
Cancer (excluding lung/haem) no 865,256 4,928 860,328 99.4 901,761
yes 196,427 840 195,587 99.6 200,802
Cancer (haematological) no 1,041,502 5,670 1,035,832 99.5 1,081,955
yes 20,174 91 20,083 99.5 20,608
brand of first dose Moderna 105 14 91 86.7 238
Oxford-AZ 289,478 3,738 285,740 98.7 289,597
Pfizer 771,407 1,995 769,412 99.7 776,356
Unknown 686 14 672 98.0 693

Footnotes:

  • Patient counts rounded to the nearest 7
  • Only persons who are currently registered and had their fist dose at least 14 weeks ago are included in the 'due' group.
  • Population excludes those known to live in an elderly care home, based upon clinical coding.
  • SSRIs group excludes individuals with Psychosis/ schizophrenia/bipolar, LD, or Dementia.

Second Doses Overdue Among 80+ Population

Second doses which have not been given at least 14 weeks since the first dose

Error bars indicate possible error caused by rounding

Back to top

Cumulative second dose vaccination figures among 70-79 population

Please refer to footnotes below table for information.

Second Doses due at 24 Nov (n) Second doses overdue (n) Second doses given (n) Second doses given (% of due) Total population
Category Group
overall overall 2,008,797 10,283 1,998,514 99.5 2,097,998
Sex F 1,054,991 5,726 1,049,265 99.5 1,100,582
M 953,799 4,557 949,242 99.5 997,402
Age band 70-74 1,142,596 6,216 1,136,380 99.5 1,198,687
75-79 866,201 4,074 862,127 99.5 899,297
Ethnicity (broad categories) Black 11,186 294 10,892 97.4 14,917
Mixed 5,572 91 5,481 98.4 6,643
Other 13,146 210 12,936 98.4 16,142
South Asian 50,533 833 49,700 98.4 57,064
Unknown 108,815 728 108,087 99.3 123,746
White 1,819,538 8,113 1,811,425 99.6 1,879,472
ethnicity 16 groups African 3,808 140 3,668 96.3 5,390
Bangladeshi or British Bangladeshi 1,624 35 1,589 97.8 1,890
Caribbean 5,320 112 5,208 97.9 6,860
Chinese 3,451 35 3,416 99.0 4,347
Other 9,674 175 9,499 98.2 11,781
Other Asian 10,017 133 9,884 98.7 11,627
British or Mixed British 1,730,127 7,357 1,722,770 99.6 1,779,491
Indian or British Indian 28,742 322 28,420 98.9 31,479
Irish 14,483 98 14,385 99.3 15,421
Other Black 2,058 49 2,009 97.6 2,667
Other White 74,928 658 74,270 99.1 84,560
Other mixed 2,240 28 2,212 98.8 2,604
Pakistani or British Pakistani 10,157 343 9,814 96.6 12,075
Unknown 108,829 728 108,101 99.3 123,753
White + Asian 1,267 14 1,253 98.9 1,428
White + Black African 868 28 840 96.8 1,106
White + Black Caribbean 1,204 21 1,183 98.3 1,512
Index of Multiple Deprivation (quintiles) 1 Most deprived 255,535 2,317 253,218 99.1 273,847
2 335,531 2,142 333,389 99.4 354,039
3 449,603 2,233 447,370 99.5 468,566
4 467,159 1,925 465,234 99.6 484,477
5 Least deprived 462,035 1,421 460,614 99.7 475,671
Unknown 38,927 245 38,682 99.4 41,384
BMI 30+ 504,434 2,282 502,152 99.5 519,036
under 30 1,504,356 8,001 1,496,355 99.5 1,578,948
Housebound no 1,969,422 9,576 1,959,846 99.5 2,056,908
yes 39,368 700 38,668 98.2 41,076
Chronic cardiac disease no 1,641,080 8,239 1,632,841 99.5 1,718,969
yes 367,710 2,037 365,673 99.4 379,015
Current COPD no 1,816,787 9,086 1,807,701 99.5 1,900,339
yes 192,003 1,197 190,806 99.4 197,645
Dialysis no 2,004,709 10,255 1,994,454 99.5 2,093,784
yes 4,081 28 4,053 99.3 4,200
DMARDs no 1,936,319 9,954 1,926,365 99.5 2,023,924
yes 72,471 329 72,142 99.5 74,060
Dementia no 1,967,329 9,870 1,957,459 99.5 2,054,997
yes 41,461 413 41,048 99.0 42,994
Psychosis, schizophrenia, or bipolar no 1,989,932 9,961 1,979,971 99.5 2,077,558
yes 18,858 322 18,536 98.3 20,426
Learning disability no 2,005,948 10,234 1,995,714 99.5 2,095,009
yes 2,842 42 2,800 98.5 2,982
SSRI (last 12 months) no 1,904,952 9,695 1,895,257 99.5 1,991,878
yes 103,845 595 103,250 99.4 106,106
Chemo or radiotherapy no 1,938,510 9,982 1,928,528 99.5 2,026,094
yes 70,280 301 69,979 99.6 71,890
Cancer (lung) no 1,995,742 10,199 1,985,543 99.5 2,084,621
yes 13,048 77 12,971 99.4 13,370
Cancer (excluding lung/haem) no 1,719,375 9,114 1,710,261 99.5 1,801,317
yes 289,422 1,169 288,253 99.6 296,674
Cancer (haematological) no 1,978,081 10,129 1,967,952 99.5 2,066,477
yes 30,709 154 30,555 99.5 31,507
brand of first dose Moderna 462 70 392 84.8 1,036
Oxford-AZ 1,212,666 7,504 1,205,162 99.4 1,212,876
Pfizer 794,192 2,660 791,532 99.7 803,075
Unknown 1,470 49 1,421 96.7 1,484

Footnotes:

  • Patient counts rounded to the nearest 7
  • Only persons who are currently registered and had their fist dose at least 14 weeks ago are included in the 'due' group.
  • Population excludes those known to live in an elderly care home, based upon clinical coding.
  • SSRIs group excludes individuals with Psychosis/ schizophrenia/bipolar, LD, or Dementia.

Second Doses Overdue Among 70-79 Population

Second doses which have not been given at least 14 weeks since the first dose

Error bars indicate possible error caused by rounding

Back to top

Cumulative second dose vaccination figures among care home population

Please refer to footnotes below table for information.

Second Doses due at 24 Nov (n) Second doses overdue (n) Second doses given (n) Second doses given (% of due) Total population
Category Group
overall overall 103,810 1,421 102,389 98.6 109,900
Sex F 72,828 882 71,946 98.8 76,853
M 30,982 539 30,443 98.3 33,054
Age band 65-69 5,691 133 5,558 97.7 6,160
70-74 8,988 182 8,806 98.0 9,632
75-79 12,845 217 12,628 98.3 13,671
80-84 18,508 259 18,249 98.6 19,628
85-89 24,437 301 24,136 98.8 25,851
90+ 33,348 336 33,012 99.0 34,958
Ethnicity (broad categories) Black 581 21 560 96.4 707
Mixed 301 7 294 97.7 322
Other 476 7 469 98.5 511
South Asian 917 28 889 96.9 1,015
Unknown 2,142 28 2,114 98.7 2,429
White 99,393 1,337 98,056 98.7 104,909
Dementia no 47,075 714 46,361 98.5 50,498
yes 56,735 714 56,021 98.7 59,402
brand of first dose Moderna 0 0 0 NaN 35
Oxford-AZ 74,326 1,204 73,122 98.4 74,382
Pfizer 29,330 224 29,106 99.2 31,752
Unknown 147 0 147 100.0 154

Footnotes:

  • Patient counts rounded to the nearest 7
  • Only persons who are currently registered and had their fist dose at least 14 weeks ago are included in the 'due' group.
  • Population includes those known to live in an elderly care home, based upon clinical coding.

Second Doses Overdue Among Care Home Population

Second doses which have not been given at least 14 weeks since the first dose

Error bars indicate possible error caused by rounding

Back to top

Cumulative second dose vaccination figures among shielding (aged 16-69) population

Please refer to footnotes below table for information.

Second Doses due at 24 Nov (n) Second doses overdue (n) Second doses given (n) Second doses given (% of due) Total population
Category Group
overall overall 745,381 17,003 728,378 97.7 826,777
newly shielded since feb 15 no 450,317 8,043 442,274 98.2 486,829
yes 295,064 8,960 286,104 97.0 339,941
Sex F 418,362 9,954 408,408 97.6 465,885
M 327,005 7,042 319,963 97.8 360,878
Age band 16-29 53,634 2,597 51,037 95.2 66,878
30-39 105,385 4,067 101,318 96.1 125,972
40-49 147,371 3,969 143,402 97.3 165,564
50-59 212,261 3,892 208,369 98.2 229,544
60-69 226,716 2,471 224,245 98.9 238,812
Ethnicity (broad categories) Black 33,411 1,372 32,039 95.9 44,695
Mixed 11,340 427 10,913 96.2 14,357
Other 14,714 434 14,280 97.1 18,158
South Asian 94,276 3,017 91,259 96.8 107,947
Unknown 23,261 441 22,820 98.1 26,509
White 568,365 11,312 557,053 98.0 615,097
Index of Multiple Deprivation (quintiles) 1 Most deprived 208,992 7,000 201,992 96.7 241,556
2 166,404 4,109 162,295 97.5 186,165
3 143,920 2,653 141,267 98.2 157,332
4 115,395 1,778 113,617 98.5 123,837
5 Least deprived 91,224 987 90,237 98.9 96,229
Unknown 19,439 469 18,970 97.6 21,644
Learning disability no 720,349 16,443 703,906 97.7 799,848
yes 25,018 553 24,465 97.8 26,915
brand of first dose Moderna 1,568 224 1,344 85.7 2,058
Oxford-AZ 473,788 11,620 462,168 97.5 474,026
Pfizer 269,493 5,124 264,369 98.1 278,698
Unknown 518 28 490 94.6 518

Footnotes:

  • Patient counts rounded to the nearest 7
  • Only persons who are currently registered and had their fist dose at least 14 weeks ago are included in the 'due' group.
  • Population excludes those over 65 known to live in an elderly care home, based upon clinical coding.

Second Doses Overdue Among Shielding (Aged 16-69) Population

Second doses which have not been given at least 14 weeks since the first dose

Error bars indicate possible error caused by rounding